DCTH: Delcath Systems, Inc. Stock

by  •  • Comments Off on DCTH: Delcath Systems, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 138.39
Enterprise Value ($M) 141.44
Book Value ($M) 15.78
Book Value / Share 0.62
Price / Book 8.77
NCAV ($M) 14.32
NCAV / Share 0.56
Price / NCAV 9.66

Profitability (mra)
Return on Invested Capital (ROIC) -1.83
Return on Assets (ROA) -1.56
Return on Equity (ROE) -4.66

Liquidity (mrq)
Quick Ratio 2.06
Current Ratio 2.26

Balance Sheet (mrq) ($M)
Current Assets 37.16
Assets 38.61
Liabilities 22.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.06
Operating Income -38.18
Net Income -47.68
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.25
Cash from Investing -19.71
Cash from Financing 51.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-25 13D/A Rosalind Advisors, Inc. 9.90 4.90
02-14 13G/A Biotechnology Value Fund L P 9.99 49.75
02-13 13G/A Vivo Opportunity Fund Holdings, L.P. 9.99
02-13 13G/A Stonepine Capital Management, LLC 0.90 -78.65
02-02 13G/A Soleus Capital Master Fund, L.P. 0.00 -100.00
01-09 13G Hirschman Orin 6.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2023
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 19,866 74,425 26.69
2024-05-02 27,844 57,038 48.82
2024-05-01 50,744 85,406 59.42
2024-04-30 37,649 43,754 86.05
2024-04-29 54,222 46,873 115.68

(click for more detail)

Similar Companies
CODX – Co-Diagnostics, Inc. CTCX – Carmell Corporation
CTSO – Cytosorbents Corporation DRIO – DarioHealth Corp.
DYNT – Dynatronics Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Delcath Systems